Logo
Login
$HOWL
$0.98 +$0.00 (0.05%) Close

Company Executives

$HOWL Management Team

Mr. Steven Bloom

Chief Business Officer

Age 64
Compensation -
Sex Male

Dr. Luke Evnin

Independent Chairman of the Board

Age 61
Compensation $147.5K USD
Sex Male

Dr. Daniel Hicklin

President

Chief Executive Officer

Director

Age 62
Compensation $2.546M USD
Sex Male

Dr. Chulani Karunatilake

Chief Technology Officer

Age 66
Compensation $3.864M USD
Sex Male

Mr. Michael Urban

Principal Financial Officer

Principal Accounting Officer

Age 45
Compensation -
Sex Male

Board of Directors

From the proxy statement filed Apr 28, 2025
Directors
9
serving now
Independent
Not stated
the proxy does not say
Average tenure
4.7 years
from year joined
CEO also chairs the board
No
Luke Evnin
Director Age On board Independent Committees Other public boards 2024 pay Source
Briggs Morrison
66 2019
6 years
 Not stated None stated Arvinas Inc., Carisma Therapeutics Inc., Syndax Pharmaceuticals, Inc. $104,479
Michael Sherman
59 2021
4 years
 Not stated
Audit Committee · Chair Compensation Committee
None stated Not stated
Anil Singhal
73 2025
0 years
 Not stated None stated None stated Not stated
Meeta Chatterjee
70 2021
4 years
 Not stated None stated None stated Not stated
Daniel J. Hicklin
CEO
 62 2017
8 years
 Not stated None stated None stated Paid as CEO
Michael B. Atkins
70 2024
1 year
 Not stated None stated None stated $279,695
Luke Evnin
Board chair
 61 2017
8 years
 Not stated
Nominating and Corporate Governance Committee · Chair
None stated Not stated
Alon Lazarus
50 2019
6 years
 Not stated
Compensation Committee · Chair
None stated Not stated
Derek DiRocco
44 2020
5 years
 Not stated None stated Acrivon Therapeutics, Inc., Mineralys Therapeutics, LLC, 89bio, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 28, 2025 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans